← Eichor
Study identifier: NCT07129148 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Mobile Health and Wearable Devices for Diabetes Complication Management

Condition: Diabetes Mellitus Type 2 · Diabetes Mellitus Complications  ·  Sponsor: Second Xiangya Hospital of Central South University

PhaseNA
Planned participants6000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The value of intelligent lifestyle intervention for T2D and its complications has been initially explored, but evidence-based support for the effectiveness of related AI risk prediction models and intervention models remains to be confirmed. The primary objective of this study is to verify the effectiveness of an AI model for predicting the risk of T2D complications based on phenotype, laboratory indicators and wearable device indicators, and to explore the effect and applicability of an intelligent lifestyle intervention model combining wearable devices and smartphones in preventing T2D complications.

This description comes directly from the study's public registry record.

Talk to the study team

HouDe Zhou, Prof.  ·  86-0731-85292223  ·  houdezhou@csu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Second Xiangya Hospital of Central South UniversityChangsha, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07129148